Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine effects on simulated flying performance under cabin pressure
NL-OMON41124Phase 4Active, not recruiting
- Sponsor
- TNO
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bilastine in allergic rhinoconjunctivitis (ARC) and urticaria, sponsored by TNO. Primary endpoints: Vigilance and Tracking Test tracking error, Vigilance and Tracking Test omissions and 7 more. Started Nov 2014; status: active, not recruiting.
02
Drugs
bilastine
03
Conditions
allergic rhinoconjunctivitis (ARC)urticaria
Beyond the preview
Go deeper on NL-OMON41124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41124.